Chargement en cours...
Immunotoxins Targeting B cell Malignancy—Progress and Problems With Immunogenicity
Few immunotoxins or targeted toxins have become mainline cancer therapies. Still immunotoxins continue to be of major interest and subject of research and development as alternative therapies for drug resistant cancer. A major matter of concern continues to be immunogenicity exemplified by the anti-...
Enregistré dans:
| Publié dans: | Biomedicines |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6466112/ https://ncbi.nlm.nih.gov/pubmed/30577664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines7010001 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|